Here are relevant reports on : food-allergy-therapeutics-market
-
Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020)
Chronic lymphocytic leukemia is the second most common cancer in adult males and rarely occurs in children. The risk of chronic lymphocytic leukemia is closely associated with age. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age. The chronic lymphocytic leukemia market is segmented into two types; namely childhood chronic lymphocytic leukemia and adulthood lymphocytic leukemia. The market was dominated by Campath drug in 2010. However, in 2020, the market is expected to be equally dominated by GA101/RG7159 molecule and Arzerra drug.
- Published: December 2011
- Price: $ 4950
- TOC Available:
-
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries
Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
Skin Health Foods Market by Indication (Skin Conditions, Anti-Aging, Anti-Allergy), Region (North America, Europe, Asia Pacific, Rest of the World), Regulatory Landscape, Pricing Analysis - Global Forecast to 2026
The global skin health foods market growth is primed to transition from $1,929.5 million in 2021 to $2,651.5 million by 2026, showcasing a strong CAGR of 6.6%. The growth of this market is mainly driven by the high incidence of allergic diseases, the growth in health awareness among consumers, increasing R&D and production capacity for functional food and beverage products, and the increasing consumption of nutrient-enriched foods to improve overall health.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Medical Gas and Equipment Market by Type (Pure Medical Gases/Mixtures), Medical Gas Equipment (Flowmeter, Medical Air Compressor)), Application (Therapeutics (Respiratory), Diagnostics), End User (Hospitals, Home Healthcare) - Global Forecast to 2029
The global medical gas and equipment market, valued at US$17.65 billion in 2022, stood at US$19.90 billion in 2023 and is projected to advance at a resilient CAGR of 5.8% from 2023 to 2029, culminating in a forecasted valuation of US$26.44 billion by the end of the period. The market is expanding significantly due to rising respiratory illnesses that necessitate frequent medical gas treatment and growing demand for effective and safe gas delivery systems. Increased emphasis on home healthcare services and regulatory support for safer gas delivery methods are expected to boost market growth.
- Published: September 2024
- Price: $ 7150
- TOC Available:
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029
The global peptide synthesis market, valued at US$0.78 billion in 2023, stood at US$0.81 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$1.41 billion by the end of the period. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
The global custom antibody market, valued at US$539 million in 2023, stood at US$579 million in 2024 and is projected to advance at a resilient CAGR of 9.2% from 2024 to 2029, culminating in a forecasted valuation of US$901 million by the end of the period. The market's growth is mainly driven by government funding and support for research in antibody-related fields, coupled with the expansion into translational medicine.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) - Global Forecast to 2029
The global bioconjugation market, valued at US$4.78 billion in 2023, stood at US$5.27 billion in 2024 and is projected to advance at a resilient CAGR of 15.6% from 2024 to 2029, culminating in a forecasted valuation of US$10.86 billion by the end of the period. The bioconjugation market is experiencing significant growth with the advancement of bioconjugation technologies, which increase precision, efficacy, and safety in therapeutic & diagnostic applications.
- Published: January 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
